SERA Sera Prognostics Inc.: Market Value

Corporate emblem and logo of Sera Prognostics, Inc. (SERA)

The Sera Prognostics business model is based on the precision of biomarker research for pregnancy risk assessment, and the price trajectory shown below at the 0.08 level illustrates the asset's market dynamics. Sera Prognostics is expanding its distribution by selling diagnostic tests to insurance organizations and clinics. Meanwhile, laboratory capacities for analyzing preterm labor remain consistently utilized and technically upgraded.

Sera Prognostics - SERA Market Capitalization (period 07/04/2022 - 11/11/2026)

SERA (Sera Prognostics Inc.): analytical breakdowns and indicator data

- current price and projected stock value:
Stock Price Sera Prognostics, Inc.|SERA - Average Forecast Price
- company stock capitalization data:
Market Value Sera Prognostics, Inc.|SERA - Value Adjusted for Debt and Cash
- book value of equity indicators:
Book Value per Share Sera Prognostics|SERA - Book Capitalization|Market Value to Book Value Ratio seraprognostics.com|SERA - Aggregate Asset Value
- debt and solvency information:
Total Debt to Capital Sera Prognostics|SERA - Long-Term Liabilities to Capital|Short-Term Debt to Equity Sera Prognostics|SERA - Company Aggregate Indebtedness|Debt to Book Capitalization Ratio Sera Prognostics, Inc.|SERA - Company Long-Term Loans and Borrowings|Company Short-Term Debt Sera Prognostics|Quick Ratio seraprognostics.com
- financial results and valuation multiples details:
SERA - Company Profit|Future Profit Sera Prognostics|SERA - P/E Multiple|Forward P/E Multiple Sera Prognostics, Inc.|SERA - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Sera Prognostics, Inc.|SERA - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Sera Prognostics|SERA - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months seraprognostics.com|SERA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Sera Prognostics
Fundamental valuation:SERA (Sera Prognostics, Inc.)
Product sample of Sera Prognostics

A portfolio analyst utilizes this tool to isolate the sector's fundamental leaders. The total value of all shares determines the issuer's market weight and its suitability for inclusion in index funds. For Sera Prognostics (SERA), this metric reflects market confidence in the scaling strategy of diagnostic IT platforms. The public company's current capitalization captures expectations regarding management's partnerships with insurance funds. The capitalization dynamics of the public company help reconcile the market price with the business's intrinsic value.

Key competitors

Market Capitalization NTRA (Natera)|Humacyte Inc (HUMA) - Market Value